Kir6.1/SUR2B channels are expressed in ductus arteriosus (DA) tissues and have been identified as a promising therapeutic target for the management of patent ductus arteriosus (PDA) [28,29]. Here, KCNJ8 is linked to Patent ductus arteriosus.